Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Long-Term Deferred Tax (2023 - 2025)

Moolec Science (MLECW) posted Long-Term Deferred Tax of -$15.8 million for Q2 2025, up 21.26% sequentially from -$20.0 million in Q2 2024, and up 21.26% YoY from -$13.0 million in Q2 2024.

Moolec Science (MLECW) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends

Moolec Science has reported Long-Term Deferred Tax for 3 years, with the latest figure at -$15.8 million in Q2 2025.

  • Quarterly Long-Term Deferred Tax rose 21.26% year-over-year to -$15.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$15.8 million (up 21.26% YoY) and the FY2025 annual result came in at -$15.8 million, up 21.26% from the prior year.
  • Long-Term Deferred Tax rose to -$15.8 million in Q2 2025 per MLECW's latest filing, from -$20.0 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at -$15.8 million in Q2 2025 and troughed at -$24.8 million in Q2 2023.
  • A 3-year average of -$20.2 million and a median of -$20.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax increased 19.38% in 2024, then advanced 21.26% in 2025.
  • Over 3 years, Long-Term Deferred Tax stood at -$24.8 million in 2023, then climbed by 19.38% to -$20.0 million in 2024, then grew by 21.26% to -$15.8 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered -$15.8 million, -$20.0 million, and -$24.8 million for Q2 2025, Q2 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Moolec Science 8,617.72 -1.19 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -15.77 Mn
Jun 30, 2024 -20.02 Mn
Jun 30, 2023 -24.84 Mn